Search Orphan Drug Designations and Approvals
-
Generic Name: | Tamibarotene |
---|---|
Date Designated: | 10/11/2007 |
Orphan Designation: | Treatment of acute promyelocytic leukemia (APL). |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CytRx Corporation 11726 San Vicente Blvd. Los Angeles, California 90049 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-